Clinical Note: Marchiafava-Bignami Disease In A Patient With Schizophrenia And Alcohol Use Disorder
Actas espanolas de psiquiatria(2021)
Abstract
Introduction. Substance-related disorders are the most frequent comorbidity in schizophrenia. Concretely, alcohol is the most commonly consumed substance after tobacco. Patients with schizophrenia with this comorbidity have a worse clinical course and can develop serious neuropsychiatric complications. One of them, Marchiafava-Bignami disease (MBD) can be incorrectly diagnosed as a decompensation of their mental disorder.Methods. A case of a 51-year-old man, diagnosed with schizophrenia and alcohol use disorder is presented. He experienced acute neuropsychiatric symptoms for which schizophrenia decompensation was suspected. Based on his atypical symptoms and medical history, a brain imaging test was performed and MBD was diagnosed.Conclusions. MBD is an infrequent clinical entity that should be part of differential diagnosis in patients with alcohol abuse disorder experiencing atypical neuropsychiatric symptoms.
MoreTranslated text
Key words
Marchiafava-Bignami disease, schizophrenia, dual disorder, alcohol use disorders
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined